Tumor Location Is Not an Independent Prognostic Factor in Early Stage Non-Small Cell Lung Cancer

Annals of Thoracic Surgery

Volumn 89, Issue 4, 2010, Pages 1053-1059

  Puri, Varun ^a   Garg, Nitin ^b   Engelhardt, Erin E ^a   Kreisel, Daniel ^a   Crabtree, Traves D ^a   Meyers, Bryan F ^a   Patterson, G Alexander ^a   Krupnick, Alexander Sasha ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CANCER SURVIVAL; DATA BASE; EARLY CANCER; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SEGMENTECTOMY; LUNG SQUAMOUS CELL CARCINOMA; LUNG WEDGE RESECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; NEUROENDOCRINE TUMOR; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77949556532     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.01.020     Document Type: Article

References (19)

1. Fry W.A., Philips J.L., and Menck H.R. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer 86 (1999) 1867-6
2. Schettino C., Bareschino M.A., Maione P., Rossi A., Ciardiello F., and Gridelli C. The potential role of pharmacogenomic and genomic in the adjuvant treatment of early stage non small cell lung cancer. Curr Genomics 9 (2008) 252-262
3. In: Kaiser L.R., and Jamieson G.G. (Eds). Operative thoracic surgery. 5th ed. (2006), Edward Arnold, New York, NY
4. Ou S.H., Zell J.A., Ziogas A., and Anton-Culver H. Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer 110 (2007) 1532-1541
5. Ichinose Y., Kato H., Koike T., et al. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg 122 (2001) 803-808
6. Rocha A.T., McCormack M., Montana G., and Schreiber G. Association between lower lobe location and upstaging for early-stage non-small cell lung cancer. Chest 125 (2004) 1424-1430
7. Inoue M., Sawabata N., Takeda S., Ohta M., Ohno Y., and Maeda H. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg 127 (2004) 1100-1106
8. Hayakawa K., Mitsuhashi N., Saito Y., et al. Impact of tumor extent and location on treatment outcome in patients with stage III non-small cell lung cancer treated with radiation therapy. Jpn J Clin Oncol 26 (1996) 221-228
9. Ciurea D., and Gil J. Morphometry of capillaries in three zones of rabbit lungs fixed by vascular perfusion. Anat Rec 244 (1996) 182-192
10. Teschler H., Konietzko N., Schoenfeld B., Ramin C., Schraps T., and Costabel U. Distribution of asbestos bodies in the human lung as determined by bronchoalveolar lavage. Am Rev Respir Dis 147 (1993) 1211-1215
11. Iwasaki A., Shirakusa T., Enatsu S., et al. Is T2 non-small cell lung cancer located in left lower lobe appropriate to upstage?. Interact Cardiovasc Thorac Surg 4 (2005) 126-129
12. Kotoulas C.S., Foroulis C.N., Kostikas K., et al. Involvement of lymphatic metastasis spread in non-small cell lung cancer according to the primary cancer location. Lung Cancer 44 (2004) 183-191
13. Cerfolio R.J., and Bryant A.S. Distribution and likelihood of lymph node metastasis based on the lobar location of nonsmall-cell lung cancer. Ann Thorac Surg 81 (2006) 1969-1973
14. Martin-Ucar A.E., Chaudhuri N., Edwards J.G., and Waller D.A. Can pneumonectomy for non-small cell lung cancer be avoided?. An audit of parenchymal sparing lung surgery. Eur J Cardiothorac Surg 21 (2002) 601-605
15. Ludwig C., Stoelben E., Olschewski M., and Hasse J. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma. Ann Thorac Surg 79 (2005) 968-973
16. Mery C.M., Pappas A.N., Bueno R., et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 128 (2005) 237-245
17. Moldvay J., Scheid P., Wild P., et al. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma. Clin Cancer Res 6 (2000) 1125-1134
18. Ichinose Y., Yano T., Asoah H., Yokoyama H., Yoshino I., and Katsuda Y. Prognostic factors obtained by a pathologic examination in completely resected non-small cell lung cancer: an analysis in each pathologic stage. J Thorac Cardiovasc Surg 110 (1995) 601-605
19. Mountain C.F., Lukeman J.M., Hammar S.P., et al. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trails population. J Surg Oncol 35 (1987) 147-156